DUSP4 Antibody

What is DUSP4 and why is it significant in research?

DUSP4 (Dual Specificity Phosphatase 4, also known as MKP-2) is a phosphatase that negatively regulates MAP kinase signaling pathways. It plays critical roles in multiple cellular processes including neuronal differentiation, T-cell activation, and tumor suppression. DUSP4 is particularly significant in research because it helps determine the duration and magnitude of MAP kinase activation, thereby influencing cell proliferation, differentiation, and survival . Recent studies have demonstrated its importance in neurogenesis of embryonic stem cells and its potential role as a prognostic marker in certain cancers, making it a valuable target for investigation in developmental biology, immunology, and oncology .

What types of DUSP4 antibodies are available for research applications?

Several types of DUSP4 antibodies are available for research purposes, each optimized for specific applications:

• Polyclonal antibodies targeting various regions (internal region, C-terminal, full-length protein)

• Monoclonal antibodies with specific epitope recognition

• Region-specific antibodies targeting amino acids 1-394, 331-361, 1-168, or 109-198

These antibodies vary in their host species (predominantly rabbit and mouse), reactivity profiles (human, mouse, rat, monkey), and validated applications (Western blotting, immunohistochemistry, ELISA, immunofluorescence) . Selection should be based on your specific experimental requirements, including target species, application method, and region of interest within the DUSP4 protein.

How does DUSP4 function in cellular signaling pathways?

DUSP4 functions as a negative regulator of MAP kinases through its phosphatase activity, removing phosphate groups from both tyrosine and threonine residues. In cellular signaling:

• DUSP4 is induced by MAP kinase activation, creating a negative feedback loop that modulates signal duration and intensity

• It targets ERK, JNK, and p38 MAP kinases with varying specificities

• Through its regulation of MAP kinases, DUSP4 influences diverse cellular processes including proliferation, differentiation, and apoptosis

• Its catalytic activity is essential for its biological functions, as demonstrated in experiments with catalytically inactive mutants

The phosphatase domain is crucial for DUSP4's regulatory function, as research has shown that reintroduction of wild-type DUSP4, but not catalytically inactive mutant DUSP4, can rescue phenotypes in DUSP4-knockdown cells .

What is the subcellular localization of DUSP4 and how does it affect antibody selection?

DUSP4 is predominantly localized to the nucleus, though it is also detected in the cytosol, as demonstrated by immunocytochemistry studies using anti-DUSP4 antibodies in both embryonic stem cells and differentiated neurons . This dual localization reflects DUSP4's role in regulating nuclear and cytoplasmic signaling processes.

When selecting antibodies for subcellular localization studies, consider:

• Antibodies validated for immunocytochemistry or immunofluorescence applications

• Permeabilization protocols that ensure access to both nuclear and cytoplasmic compartments

• Co-staining with appropriate subcellular markers to confirm localization patterns

• Antibodies raised against epitopes that are accessible in the protein's native conformation

Understanding the subcellular distribution of DUSP4 is important when designing experiments to study its interactions with MAP kinases and other signaling components in different cellular compartments.

How should researchers optimize Western blotting protocols for DUSP4 detection?

For optimal Western blotting results with DUSP4 antibodies, consider the following methodological recommendations:

• Sample preparation: Include phosphatase inhibitors in lysis buffers to preserve the native state of DUSP4 and its substrates

• Protein loading: 20-50 μg of total protein is typically sufficient for detection of endogenous DUSP4

• Antibody selection: Choose antibodies specifically validated for Western blotting applications, such as the polyclonal antibodies targeting internal regions of DUSP4

• Antibody dilution: Start with manufacturer-recommended dilutions (typically 1:200 to 1:1000) and optimize as needed

• Detection controls: Include positive controls (tissues known to express DUSP4, such as neuronal cells) and negative controls (DUSP4-knockdown cells)

• Expected molecular weight: Look for bands at approximately 43-45 kDa, which corresponds to the molecular weight of DUSP4

When studying DUSP4 in neuronal differentiation models, Western blotting has successfully demonstrated upregulation of DUSP4 protein during differentiation processes, providing a reliable readout of expression levels .

What are the best practices for immunohistochemical detection of DUSP4?

For effective immunohistochemical detection of DUSP4 in tissue samples, follow these methodological guidelines:

• Tissue preparation: Use 4 μm sections from formalin-fixed, paraffin-embedded tissues

• Antigen retrieval: Perform heat-induced epitope retrieval (100°C for 20 minutes in sodium citrate buffer)

• Endogenous peroxidase blocking: Treat with peroxidase-blocking solution for 15 minutes

• Primary antibody incubation: Use DUSP4 antibody at appropriate dilution (e.g., 1:200 for Rabbit DUSP4 polyclonal antibody) and incubate overnight at 4°C

• Detection system: Apply labeled polymer and 3,3'-diaminobenzidine tetrahydrochloride chromogen according to manufacturer's instructions

• Expression evaluation: Assess staining intensity and percentage of positive cells to determine expression levels

This protocol has been successfully used in large-scale studies examining DUSP4 expression in gastric cancer samples, demonstrating associations between expression levels and clinicopathological features .

How can DUSP4 antibodies be used to evaluate neuronal differentiation?

DUSP4 antibodies can be valuable tools for monitoring neuronal differentiation, as DUSP4 is significantly upregulated during this process. Methodological approaches include:

• Temporal expression analysis: Use Western blotting with DUSP4 antibodies to track expression levels at different stages of differentiation

• Immunocytochemistry: Visualize DUSP4 localization in undifferentiated embryonic stem cells versus differentiated neurons

• Co-localization studies: Combine DUSP4 antibodies with neuronal markers (MAP2, β-tubulin III) to correlate DUSP4 expression with differentiation status

• Functional studies: Compare DUSP4 expression in normal versus DUSP4-knockdown cells to assess effects on neuronal morphology and marker expression

Research has demonstrated that DUSP4 is dramatically upregulated during neuronal differentiation of mouse embryonic stem cells and during in vivo brain development, making DUSP4 antibodies useful indicators of neurogenic progression .

What controls should be included when using DUSP4 antibodies in experimental designs?

To ensure reliable and interpretable results with DUSP4 antibodies, incorporate these essential controls:

• Positive tissue controls: Include samples known to express DUSP4 (neuronal cells, specific T-cell populations)

• Negative controls: Omit primary antibody but include all other reagents to detect non-specific binding

• Knockdown/knockout controls: Use DUSP4-depleted cells (via shRNA or CRISPR) to confirm antibody specificity

• Isotype controls: Include appropriate isotype-matched control antibodies (e.g., rabbit or mouse IgG)

• Expression validation: When possible, verify protein expression with gene expression analysis

• Peptide competition: Pre-incubate antibody with immunizing peptide to demonstrate binding specificity

These controls are particularly important when studying DUSP4 in complex systems where expression may be dynamic, such as during neuronal differentiation or T-cell activation processes.

How do you troubleshoot weak or non-specific signals when using DUSP4 antibodies?

When encountering weak or non-specific signals with DUSP4 antibodies, consider these methodological troubleshooting approaches:

• For weak signals:

  • Increase antibody concentration or incubation time

  • Optimize antigen retrieval methods (try different buffers or durations)

  • Use signal amplification systems (e.g., biotin-streptavidin)

  • Ensure sample preparation preserves DUSP4 (use protease/phosphatase inhibitors)

  • Check if DUSP4 expression is dynamically regulated in your system

• For non-specific signals:

  • Increase blocking duration or concentration

  • Try different blocking agents (BSA, normal serum, commercial blockers)

  • Perform additional washing steps with higher stringency

  • Use more selective antibodies (consider monoclonal vs. polyclonal)

  • Validate with alternative detection methods or antibodies targeting different epitopes

DUSP4 expression can vary significantly between cell types and developmental stages, so understanding the expected expression pattern in your experimental system is crucial for interpreting signals correctly .

What are the differences between polyclonal and monoclonal DUSP4 antibodies in research applications?

The choice between polyclonal and monoclonal antibodies should be guided by your specific experimental needs. Polyclonal antibodies may be preferable for detection of low-abundance DUSP4 in varied applications, while monoclonal antibodies offer greater specificity and reproducibility for targeted analyses or when cross-reactivity with other DUSP family members is a concern .

How can researchers validate DUSP4 antibody specificity in their experimental systems?

Validating DUSP4 antibody specificity is crucial for generating reliable data. Use these methodological approaches:

• Genetic validation:

  • Test antibody in DUSP4 knockdown/knockout models (using shRNA or CRISPR/Cas9)

  • Compare staining patterns between wildtype and DUSP4-deficient samples

• Expression validation:

  • Correlate protein detection with mRNA expression levels

  • Verify expression patterns in tissues known to express DUSP4 versus those with minimal expression

• Protein validation:

  • Detect overexpressed FLAG-tagged DUSP4 with both anti-FLAG and anti-DUSP4 antibodies

  • Compare detection patterns between wildtype and mutant DUSP4 proteins

• Orthogonal techniques:

  • Confirm findings using alternative antibodies targeting different DUSP4 epitopes

  • Employ multiple detection methods (WB, IHC, IF) to cross-validate findings

Robust validation is particularly important when studying DUSP4 in systems where its expression is dynamically regulated, such as during neuronal differentiation or immune cell activation .

What are the critical factors for preserving DUSP4 phosphatase activity in experimental samples?

Preserving DUSP4's native phosphatase activity is essential for functional studies. Consider these methodological precautions:

• Sample handling:

  • Process tissues/cells rapidly to prevent degradation

  • Maintain samples at 4°C during processing

  • Use phosphatase inhibitors selectively (to preserve DUSP4 activity while preventing substrate dephosphorylation)

• Buffer composition:

  • Include protease inhibitors to prevent proteolytic degradation

  • Avoid strong reducing agents that may disrupt catalytic cysteine residues

  • Maintain physiological pH (around 7.4) to preserve enzymatic function

• Storage conditions:

  • Avoid repeated freeze-thaw cycles

  • Store protein extracts at -80°C for long-term preservation

  • Consider adding glycerol (10-20%) for stability during storage

• Activity considerations:

  • Remember that catalytic activity is essential for DUSP4 function, as demonstrated by studies comparing wildtype and catalytically inactive mutant DUSP4 (Cys-284 to Ser mutation)

  • Some experimental conditions may artificially alter DUSP4 activity

These precautions are particularly important when designing experiments to study DUSP4's functional role in processes like neuronal differentiation, where its phosphatase activity is critical for biological outcomes .

How does DUSP4 regulate MAP kinase signaling during neuronal differentiation?

DUSP4 plays a crucial role in neuronal differentiation through specific regulation of MAP kinase signaling. Research findings demonstrate:

• DUSP4 is dramatically upregulated during neuronal differentiation of mouse embryonic stem cells (mESCs) and during in vivo brain development

• Knockdown of DUSP4 in mESCs significantly impairs neuronal differentiation:

  • Decreased neurite outgrowth in MAP2-positive cells

  • Reduced expression of neural progenitor markers (nestin)

  • Diminished expression of neuronal-specific genes (MAP2, β-tubulin III, synaptophysin)

• The catalytic phosphatase activity of DUSP4 is essential for promoting neuronal differentiation:

  • Reintroduction of wild-type DUSP4, but not catalytically inactive mutant DUSP4, rescues the differentiation defects in DUSP4-knockdown cells

  • This indicates that DUSP4's ability to dephosphorylate MAP kinases is mechanistically important for neurogenesis

• DUSP4 likely regulates the duration and magnitude of MAP kinase activation during differentiation, creating a favorable signaling environment for neuronal development

These findings highlight DUSP4 as a potential therapeutic target for neurodegenerative diseases or neural regeneration strategies .

What is the relationship between DUSP4 expression and cancer progression?

Research examining DUSP4 expression in cancer reveals important correlations with disease progression and patient outcomes:

This evidence positions DUSP4 as a potential prognostic biomarker and therapeutic target in cancer management, particularly for aggressive gastric cancers where DUSP4 expression is diminished .

How does DUSP4 deficiency affect CD4+ T-cell proliferation and immune response?

Studies using DUSP4-deficient mice have revealed specific effects on T-cell function and immune responses:

• DUSP4 deficiency results in hyperproliferation of CD4+ T cells, while CD8+ T-cell proliferation remains normal

• The mechanism underlying enhanced CD4+ T-cell proliferation involves:

  • Increased CD25 expression on CD4+ T cells

  • Enhanced IL-2 signaling

  • Elevated STAT5 phosphorylation

• In vivo immunization of DUSP4-deficient mice:

  • Recapitulates the T-cell hyperproliferation phenotype in antigen recall responses

  • Does not alter the profile of Th1/Th2-polarized antibody production

• Other dual-specificity phosphatases likely compensate for DUSP4 deficiency in:

  • T-cell development

  • MAP kinase regulation

  • Th1/Th2-mediated antibody responses

These findings reveal a novel role for DUSP4 in regulating T-cell activation and proliferation beyond direct MAP kinase regulation, with potential implications for understanding autoimmune disorders and designing immunotherapeutic approaches .

What techniques can be used to study DUSP4 interactions with its substrates?

Advanced methodological approaches for studying DUSP4-substrate interactions include:

• Co-immunoprecipitation (Co-IP):

  • Use DUSP4 antibodies to pull down DUSP4 along with its binding partners

  • Western blot with antibodies against MAP kinases (ERK, JNK, p38) to detect interactions

  • Include substrate-trapping mutants (e.g., C284S) that bind substrates but cannot dephosphorylate them, potentially stabilizing interactions

• Proximity Ligation Assay (PLA):

  • Detect protein-protein interactions in situ with specific antibodies

  • Visualize DUSP4-substrate proximity in different cellular compartments

  • Particularly useful for antibodies validated for PLA applications

• Phosphatase Activity Assays:

  • Compare dephosphorylation of purified, phosphorylated MAP kinases by wild-type versus mutant DUSP4

  • Use phospho-specific antibodies to monitor substrate dephosphorylation

  • Employ synthetic phosphopeptides that mimic DUSP4 substrate sites

• Live-cell Imaging:

  • Generate fluorescently tagged DUSP4 and substrate proteins

  • Monitor interactions in real-time using FRET or BiFC techniques

  • Observe dynamics of interactions during cellular processes like differentiation

These approaches can provide complementary insights into how DUSP4 selects and regulates its substrates in different cellular contexts and signaling pathways.

How can DUSP4 antibodies be utilized in cancer prognosis research?

DUSP4 antibodies have emerging value in cancer prognostic research based on recent findings:

• Immunohistochemical scoring systems:

  • DUSP4 expression can be evaluated in tumor tissues using immunohistochemistry with specific antibodies

  • Expression levels can be quantified based on staining intensity and percentage of positive cells

  • These scores can be correlated with clinicopathological features and patient outcomes

• Prognostic associations:

  • In gastric cancer studies, low DUSP4 expression correlates with aggressive tumor characteristics and worse survival outcomes

  • Statistical analyses (Kaplan-Meier method, log-rank test, Cox regression) can identify DUSP4 as an independent prognostic factor

• Methodological approach:

  • Use heat-induced epitope retrieval (100°C for 20 min in sodium citrate buffer)

  • Block endogenous peroxidase using peroxidase-blocking solution for 15 min

  • Incubate with diluted DUSP4 antibody (1:200, Rabbit DUSP4 polyclonal antibody)

  • Apply detection system according to manufacturer's protocol

• Integration with molecular profiling:

  • Combine DUSP4 immunohistochemistry with molecular classification systems (e.g., TCGA)

  • Assess relationship between DUSP4 expression and specific molecular alterations (e.g., HER2 amplification)

These applications position DUSP4 antibodies as valuable tools in translational cancer research, potentially informing patient stratification and treatment decisions .

What are the challenges in developing therapeutic strategies targeting DUSP4?

Developing therapeutic strategies targeting DUSP4 presents several methodological and conceptual challenges:

• Dual role in different contexts:

  • DUSP4 appears to function as a tumor suppressor in some cancers, where low expression correlates with aggressive disease

  • In T-cell function, DUSP4 deficiency enhances CD4+ T-cell proliferation, suggesting a negative regulatory role in immune responses

  • These context-dependent functions complicate therapeutic targeting

• Phosphatase activity modulation:

  • Developing specific inhibitors or activators of phosphatase enzymes is technically challenging

  • The catalytic domain shares similarities with other DUSP family members, raising specificity concerns

  • The importance of catalytic activity is demonstrated by the inability of catalytically inactive mutant DUSP4 to rescue phenotypes in knockout models

• Compensatory mechanisms:

  • Evidence suggests other DUSPs may compensate for DUSP4 deficiency in certain contexts

  • This functional redundancy could limit therapeutic efficacy of DUSP4-targeted approaches

• Tissue-specific considerations:

  • DUSP4 expression and function vary significantly across tissue types

  • Neuronal cells show substantial upregulation during differentiation

  • Targeting approaches may need tissue-specific delivery systems

Understanding these challenges is essential for researchers developing DUSP4-modulating therapies for cancer, neurological disorders, or immune-related conditions.

How can researchers incorporate DUSP4 analysis in neurodevelopmental disorder studies?

Based on DUSP4's established role in neuronal differentiation, researchers can incorporate DUSP4 analysis in neurodevelopmental disorder studies through these methodological approaches:

• Expression profiling:

  • Analyze DUSP4 expression levels in neural tissues from neurodevelopmental disorder models using DUSP4 antibodies

  • Compare expression patterns during critical developmental windows using immunohistochemistry and Western blotting

• Functional studies:

  • Generate DUSP4 knockdown/knockout models to assess effects on neuronal differentiation and function

  • Evaluate neurite outgrowth, neural marker expression, and electrophysiological properties

  • Use lentiviral systems for gene manipulation as demonstrated in embryonic stem cell models

• Rescue experiments:

  • Test whether reintroduction of wild-type DUSP4 can rescue neurodevelopmental phenotypes

  • Compare efficacy of wild-type versus catalytically inactive mutant DUSP4, as phosphatase activity is essential for function

• Signaling pathway analysis:

  • Investigate crosstalk between DUSP4 and known neurodevelopmental pathways

  • Examine MAP kinase activation patterns in normal versus affected neural tissues

  • Use specific DUSP4 antibodies to track protein expression and localization during development

The significant upregulation of DUSP4 during neuronal differentiation and brain development suggests it may play an underexplored role in neurodevelopmental disorders, making it a promising target for future research .

What emerging techniques might enhance DUSP4 antibody applications in research?

Several emerging techniques show promise for expanding DUSP4 antibody applications:

• Single-cell analysis:

  • Apply DUSP4 antibodies in mass cytometry (CyTOF) to analyze expression at single-cell resolution

  • Integrate with single-cell transcriptomics to correlate protein and mRNA expression

  • Study heterogeneity of DUSP4 expression in mixed cell populations (particularly relevant for immune and cancer studies)

• Advanced imaging:

  • Implement super-resolution microscopy with DUSP4 antibodies to visualize subcellular localization with nanometer precision

  • Apply expansion microscopy to enhance visualization of DUSP4 in complex tissues

  • Develop in vivo imaging applications with labeled DUSP4 antibodies or fragments

• Antibody engineering:

  • Create recombinant antibody fragments (Fab, scFv) for improved tissue penetration

  • Develop bispecific antibodies targeting DUSP4 and its substrates simultaneously

  • Engineer phospho-specific DUSP4 antibodies to detect post-translational modifications

• Spatial transcriptomics integration:

  • Combine DUSP4 antibody staining with spatial transcriptomics to correlate protein expression with spatial gene expression patterns

  • Particularly relevant for studying DUSP4 in developmental contexts and heterogeneous tissues

These technological advances will enable more sophisticated analysis of DUSP4 biology in complex systems, potentially revealing new functions and regulatory mechanisms.

How might comparative studies of different DUSP family members inform our understanding of DUSP4?

Comparative studies of DUSP family members can provide valuable insights into DUSP4 function through these methodological approaches:

• Substrate specificity analysis:

  • Use antibodies against different DUSP family members to compare expression patterns

  • Analyze substrate preferences through in vitro phosphatase assays

  • Determine structural features that distinguish DUSP4's substrate binding from other family members

• Expression pattern comparisons:

  • Map expression of multiple DUSP family members during processes like neuronal differentiation or immune cell activation

  • Identify unique versus overlapping expression patterns that might explain functional redundancy or compensation observed in DUSP4-deficient systems

• Knockout comparisons:

  • Generate and compare phenotypes of different DUSP knockout models

  • Analyze double or triple knockouts to reveal functional redundancy

  • Assess which DUSPs might compensate for DUSP4 deficiency in T-cell development and MAP kinase regulation

• Evolutionary analysis:

  • Compare conservation of DUSP4 versus other family members across species

  • Identify conserved domains and regulatory elements using bioinformatics approaches

  • Relate evolutionary constraints to functional importance

Such comparative studies will provide a more comprehensive understanding of DUSP4's unique roles within the broader context of MAP kinase regulation and cellular signaling.